Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Spoke Sciences

Spoke Sciences is a technology development company that modernizes the formulation and delivery of plant-derived functional ingredients.
2021
02-Oct
02-10
Seattle, Washington, United States
  • Industrial Manufacturing
  • Ingredients
  • Nutraceuticals (e.g. Supplements)

Innovation

Industry Problem

Many plant-derived bioactives have poor solubility, stability, taste, or absorption, limiting their use in products.

R&D Focus

Solubility, stability and bioavailability of plant bioactives

Innovative Solution

Spoke Sciences is a technology development company that modernizes the formulation and delivery of plant-derived functional ingredients. It offers advanced functional ingredients, formulated to solve solubility, stability, and taste problems to help clients solve industry pain points that stem from plant-based compounds.

Investment Funding

Last Funding Stage

Pre-Seed

Total Funding Amount

720.05K

Last Funding Amount

720.05K

Last Funding Date

14-10-2021

Startup Stage

Seed

People

Founders

About

Spoke Sciences is a technology development company that modernizes the formulation and delivery of plant-derived functional ingredients. It offers advanced functional ingredients, formulated to solve solubility, stability, and taste problems to help clients solve industry pain points that stem from plant-based compounds.

Products

Product

IsoCaps® CoQ10, Physik® and the SNAC® delivery platform – formulations designed to improve bioavailability of plant-derived compounds.

Star Product

SNAC® platform – acquired patent estate with broad delivery applications.

Demo Product or Complete Product?

Complete B2B ingredient/product – commercially available.

Future Plan

Investment Funding

Received investment from Ben Franklin Technology Partners as part of a seed funding round.

M&A and Collabs

Collab

Ben Franklin Technology Partners – seed-stage investment support.

Acquisitions

Acquired the SNAC® drug-delivery patent portfolio from Receptor Life Sciences in July 2023.

Something missing or incorrect on this page? Help us enrich this information